Back to Search
WALTER STADLER, MD
MD
Hematology & Oncology Physician
NPI: 1033272547IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
036081259(IL)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1988
Research & Publications (20)
Angiogenesis inhibition in non-clear cell renal cancer.
PMID 18654117·Clin Adv Hematol Oncol·2008
6-review
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
PMID 17569043·Cancer Chemother Pharmacol·2008
3-trial
Sunitinib--a new standard of care for metastatic renal cell carcinoma.
PMID 17593923·Nat Clin Pract Oncol·2007
8-other
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
PMID 17431101·Mol Cancer Ther·2007
6-review
Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
PMID 17363513·Clin Cancer Res·2007
6-review
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.
PMID 16909426·Cancer·2006
3-trial
A phase II study of depsipeptide in refractory metastatic renal cell cancer.
PMID 16859580·Clin Genitourin Cancer·2006
3-trial
Development of growth inhibitory agents in urological and other malignancies.
PMID 16827906·BJU Int·2006
6-review
Targeted agents for the treatment of advanced renal cell carcinoma.
PMID 16240452·Cancer·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2520 ELISHA AVENUE
ZION, IL 60099 - Phone
- (800) 322-9183
Quick Facts
- NPI
- 1033272547
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile